Orphan Drugs Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2029

The global orphan drugs market is anticipated to grow at a CAGR of 11.8% during the forecast period (2023-2030). Enzyme replacement therapy (ERT), gene therapy, small molecule drugs, biologics, and stem cell therapy are type of treatments used to cure rare diseases. 

The market’s growth is attributed to advancements in biotechnology and personalized medicine across the globe. The development of targeted medicines has become possible owing to the developments in biotechnology, genetics, and precision medicine. The advancements can be particularly significant for treating rare disorders, where a one-size-fits-all strategy can prove to be efficient. According to the National Institute of Health (NIH.gov), in February 2023, NMOSD is a rare chronic, autoimmune-mediated disease that affects the nervous system, primarily damaging the optic nerves and the spinal cord. It is estimated to affect 0.37 to 10 people per 100,000, with a female predominance and a median age of onset of 32 to 41 years. The diagnosis includes clinical criteria and MRI findings, as well as the presence of antibodies against the aquaporin-4 water channel (AQP4). If the serological testing is unavailable or the antigens for AQP4 are negative, more extensive clinical and imagistic tests may be needed. Generally, the disability resulting from NMOSD is caused by severe demyelination and extensive axonal damage. NMOSD is a pathology which involves interleukin-6. Its main symptoms are bilateral optic neuritis, transverse myelitis, pain in the legs and trunk, intractable hiccups, nausea, or vomiting, excessive somnolence or narcolepsy, reversible posterior encephalopathy syndrome, hypothalamic dysfunction, autonomic manifestations, and seizures. Investigations include spinal cord MRI, brain MRI, and MRI of the orbits.

To Request a Sample of our Report on Orphan Drugs Market:  https://www.omrglobal.com/request-sample/orphan-drugs-market

Market Coverage

•                 The market number available for – 2022-2030

•                 Base year- 2022

•                 Forecast period- 2023-2030

Segment Covered- 

•                 By Drug Type

•                 By Disease Type

•                 By Distribution Channel

Regions Covered-

•                 North America

•                 Europe

•                 Asia-Pacific

•                 Rest of the World

Competitive Landscape- includes AstraZeneca., At F. Hoffmann-La Roche Ltd, Bayer AG, Bristol-Myers Squibb India Pvt. Ltd., Daiichi Sankyo Co. Ltd., and others.

Orphan Drugs Market Report Segment

By Drug Type

•                 Biological

•                 Non-biological

By Disease Type

•                 Oncology

•                 Hematology

•                 Neurology

•                 Cardiovascular

•                 Others (Autoimmune Diseases, and Rare Blood Disorders)

By Distribution Channel

•                 Hospital Pharmacy

•                 Retail Pharmacy

•                 Online Pharmacy

•                 Others (Specialty Pharmacies, and Direct-to-Patient Distribution)

A full Report of Orphan Drugs Market is Available @  https://www.omrglobal.com/industry-reports/orphan-drugs-market

Orphan Drugs Market Report Segment by Region

North America                                                                                                           

·        United States

·        Canada                     

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan              

·                  South Korea

·                  Rest of APAC

Rest of the World

•       Latin America

•       Middle East and Africa 

Company Profiles

•                 AstraZeneca.

•                 At F. Hoffmann-La Roche Ltd

•                 Bayer AG

•                 Bristol-Myers Squibb India Pvt. Ltd.

•                 Daiichi Sankyo Co. Ltd.

•                 GlaxoSmithKline plc

•                 Johnson & Johnson Pvt. Ltd.

•                 Novartis AG

•                 Pfizer Inc.

•                 Sanofi 

•                 Takeda Pharmaceutical Co. Ltd.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/orphan-drugs-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

 

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more